Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the Safety and Performance of Percutaneous Implantation of the Venus MedTech Aortic Valve Prosthesis for Patients Who Cannot Undergo Surgical Valve Replacement

NCT01683474 is registered in ClinicalTrials.gov with Venus MedTech (HangZhou) Inc. as lead sponsor.

NCT NCT01683474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01683474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the Safety and Performance of Percutaneous Implantation of the Venus MedTech Aortic Valve Prosthesis for Patients Who Cannot Undergo Surgical Valve Replacement
Lead sponsor
Venus MedTech (HangZhou) Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2012
Completion date
April 30, 2016
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve calcification, aortic valve stenosis